Tests a high-fiber diet in people with lung cancer receiving immunotherapy
Tests a diet higher in fiber in adults with lung cancer on immunotherapy.
Plain-language title generated from the registry record
Registry title: Dietary Intervention for NSCLC Patients Treated With ICI
Key facts
- Where
- Montreal, CanadaSee the site
Where in Canada
- Centre Hospitalier de l'Universite de Montreal (CHUM)Montreal, CanadaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Centre hospitalier de l'Université de Montréal (CHUM)
- Trial code
- NCT05805319
- Record updated
- 22 October 2026
- Original description
This is a single-center randomized trial in patients with non-small cell lung cancer (NSCLC) treated with immune checkpoint inhibition. Patients will receive standard-of-care immune checkpoint inhibitor (ICI) therapy alone or in combination with a dietary intervention.Read full original descriptionShow less
Randomized Dietary Intervention to Improve Fiber Intake in Patients With Non-small Cell Lung Cancer Treated With Immune Checkpoint Inhibitor Therapy
This is a single-center randomized trial in patients with non-small cell lung cancer (NSCLC) treated with immune checkpoint inhibition. Patients will receive standard-of-care immune checkpoint inhibitor (ICI) therapy alone or in combination with a dietary intervention.
Inclusion: Signed, informed consent; Age 18 years or older; Confirmed histological diagnosis of non-small cell lung cancer (NSCLC); Treatment with standard-of-care ICI; Ability to eat solid foods.
Exclusion: Severe dietary allergies (e.g. shellfish, nuts, seafood); Has known psychiatric or substance abuse disorders that would interfere with cooperation with the requirements of the trial.